Rabeprazole sodium 20 mg
Proton Pump Inhibitor

Bepra (rabeprazole), a substituted benzimidazole, inhibits gastric acid secretion. It is indicated in the treatment of benign gastric & duodenal ulcers, erosive or ulcerative gastro-oesophageal reflux disease (GORD), Zollinger-Ellison syndrome, as well as, one of the triple therapy of Helicobacter pylori.


For more information about this product click on the links below:

+ Professionals

+ Consumer

+ Diseases & conditions

Copyright © 2017 Global Napi Pharmaceuticals.All rights reserved.
Designed & Developed by | VisionApps Team.